878570799	878570799	CD	B-NP	O
|	|	NN	I-NP	O
SSMC	SSMC	NN	I-NP	O
|	|	NN	I-NP	O
87322051	87322051	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
421285	421285	CD	B-NP	O
|	|	CC	I-NP	O
3/10/2002	3/10/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
lower	low	JJR	I-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	VBD	B-VP	O
|	|	NNP	B-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/13/2002	11/13/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
3/26/2002	3/26/2002	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
VILLARI	VILLARI	NNP	B-NP	O
,	,	,	O	O
SAUL	SAUL	NNP	B-NP	O
R	R	NNP	I-NP	O
364-17-17-6	364-17-17-6	CD	I-NP	O
Wa	Wa	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
2/5/02	2/5/02	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BAUDRY	BAUDRY	NNP	B-NP	O
,	,	,	O	O
RICKY	RICKY	NNP	B-NP	O
REGINALD	REGINALD	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
TYLENOL	TYLENOL	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ACETAMINOPHEN	ACETAMINOPHEN	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
650	650	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q6H	Q6H	NN	I-NP	I-protein
ALLOPURINOL	ALLOPURINOL	NN	I-NP	I-protein
300	300	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
FOLATE	FOLATE	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
FOLIC	FOLIC	NN	I-NP	I-protein
ACID	ACID	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
1	1	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
ZESTRIL	ZESTRIL	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
LISINOPRIL	LISINOPRIL	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/15/02	9/15/02	CD	B-NP	O
by	by	IN	B-PP	O
BOYDE	BOYDE	NNP	B-NP	O
,	,	,	O	O
SCOTTY	SCOTTY	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	I-NP	O
OXYCODONE	OXYCODONE	NN	I-NP	O
5-10	5-10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
joint	joint	JJ	I-NP	O
pain	pain	NN	I-NP	O
MVI	MVI	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
THERAPEUTIC	THERAPEUTIC	NN	I-NP	O
MULTIVITAMINS	MULTIVITAMINS	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
TORSEMIDE	TORSEMIDE	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
MICONAZOLE	MICONAZOLE	NNP	I-NP	O
NITRATE	NITRATE	NNP	I-NP	O
2	2	CD	I-NP	O
%	%	NN	I-NP	O
POWDER	POWDER	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
BID	BID	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
apply	apply	VB	B-VP	O
to	to	TO	B-PP	O
groins	groin	NNS	B-NP	O
CELEXA	CELEXA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
CITALOPRAM	CITALOPRAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/14/02	9/14/02	CD	B-NP	O
by	by	IN	B-PP	O
SIEGWARTH	SIEGWARTH	NN	B-NP	O
,	,	,	O	O
HAI	HAI	NNP	B-NP	O
GALE	GALE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
FENTANYL	FENTANYL	NN	B-NP	O
CITRATE	CITRATE	NN	I-NP	O
IV	IV	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
24840272	24840272	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CITALOPRAM	CITALOPRAM	NNP	B-NP	O
HYDROBROMIDE	HYDROBROMIDE	NNP	I-NP	O
&	&	CC	I-NP	O
FENTANYL	FENTANYL	NNP	I-NP	O
CITRATE	CITRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
THIAMINE	THIAMINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PRILOSEC	PRILOSEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
COLCHICINE	COLCHICINE	NN	I-NP	O
1.2	1.2	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q6-8H	Q6-8H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
ankle	ankle	NN	I-NP	O
or	or	CC	O	O
joint	joint	JJ	B-NP	O
pain	pain	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
Restrictions	Restriction	NNS	I-NP	O
RETURN	RETURN	NNP	B-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Lou	Lou	NNP	B-NP	O
Gaver	Gaver	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PCP	PCP	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
next	next	JJ	B-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
Colonoscopy	Colonoscopy	NNP	B-NP	O
-	-	HYPH	B-NP	O
FMH	FMH	NNP	I-NP	O
Monday	Monday	NNP	I-NP	O
5/13	5/13	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Penicillins	Penicillin	NNS	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Lower	Lower	NNP	B-NP	O
GI	GI	NNP	I-NP	O
bleed	bleed	VBD	B-VP	O
PRINCIPAL	PRINCIPAL	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
lower	low	JJR	B-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
Morbid	Morbid	NNP	I-NP	O
Obesitiy	Obesitiy	NNP	I-NP	O
;	;	:	O	O
atrial	atrial	JJ	B-NP	O
fibrilation	fibrilation	NN	I-NP	O
;	;	:	O	O
anxiety	anxiety	NN	B-NP	O
;	;	:	O	O
-RRB-	-RRB-	SYM	B-NP	O
depression	depression	NN	I-NP	O
;	;	:	O	O
sleep	sleep	JJ	B-NP	O
apnea	apnea	NN	I-NP	O
;	;	:	O	O
copd	copd	NN	B-NP	O
;	;	:	O	O
chf	chf	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gout	gout	NN	I-NP	O
;	;	:	O	O
anemia	anemia	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
osteoarthritis	osteoarthritis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
osteoarthritis	osteoarthritis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
;	;	:	O	O
h/o	h/o	NN	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
colonoscopy	colonoscopy	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
62yo	62yo	CD	B-NP	O
M	M	NN	I-NP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
morbid	morbid	NN	I-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
Afib	Afib	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
not	not	RB	B-NP	O
anticoagulated	anticoagulate	VBN	I-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
Pointden	Pointden	NNP	B-NP	O
University	University	NNP	I-NP	O
Of	Of	NNP	I-NP	O
Health	Health	NNP	I-NP	O
Center	Center	NNP	I-NP	O
on	on	IN	B-PP	O
4/29/02	4/29/02	CD	B-NP	O
complaining	complaining	NN	I-NP	O
of	of	IN	B-PP	O
signigicant	signigicant	JJ	B-NP	O
rectal	rectal	JJ	I-NP	O
bright	bright	JJ	I-NP	O
red	red	JJ	I-NP	O
blood	blood	NN	I-NP	O
per	per	IN	B-PP	O
rectum	rectum	NN	B-NP	O
,	,	,	O	O
weakness	weakness	NN	B-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
diaphoresis	diaphoresis	NN	B-NP	O
.	.	.	O	O

HPI	HPI	LS	B-LST	B-cell_type
:	:	:	O	O
Pt	Pt	NN	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
in	in	IN	B-PP	O
usual	usual	JJ	B-NP	O
state	state	NN	I-NP	O
of	of	IN	B-PP	O
health	health	NN	B-NP	O
until	until	IN	B-PP	O
7/10	7/10	CD	B-NP	O
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
noted	note	VBD	B-VP	O
2	2	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
blood	blood	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
stool	stool	NN	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
lower	low	JJR	B-NP	O
abdominal	abdominal	JJ	I-NP	O
cramping	cramping	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
9/10	9/10	CD	B-NP	O
he	he	PRP	B-NP	O
began	begin	VBD	B-VP	O
to	to	TO	I-VP	O
bleed	bleed	VB	I-VP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
rectum	rectum	NN	I-NP	O
while	while	IN	B-SBAR	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
and	and	CC	O	O
also	also	RB	B-VP	O
began	begin	VBD	I-VP	O
to	to	TO	I-VP	O
feel	feel	VB	I-VP	O
weak	weak	JJ	B-ADJP	O
,	,	,	O	O
light	light	JJ	O	O
headed	headed	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
diaphoretic	diaphoretic	JJ	I-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
experienced	experience	VBD	B-VP	O
nausea	nausea	NN	B-NP	O
and	and	CC	I-NP	O
LLQ	LLQ	NN	I-NP	O
cramping	cramping	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
denied	deny	VBD	B-VP	O
fever	fever	NN	B-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
palpitations	palpitation	NNS	B-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
denied	deny	VBD	B-VP	O
dysphagia	dysphagia	NN	B-NP	O
,	,	,	O	O
odynophagia	odynophagia	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
hematemesis	hematemesis	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
BH	BH	NN	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
BP	BP	NN	I-NP	O
of	of	IN	B-PP	O
79/48	79/48	CD	B-NP	O
,	,	,	O	O
P	P	NN	B-NP	B-protein
83	83	CD	I-NP	I-protein
,	,	,	O	O
anda	anda	CC	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
28.2	28.2	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
2U	2U	NN	B-NP	O
PRBC	PRBC	NN	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
improvement	improvement	NN	B-NP	O
in	in	IN	B-PP	O
BP	BP	NN	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
tagged	tag	VBN	I-NP	O
RBC	RBC	NN	I-NP	O
scan	scan	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/21	10/21	CD	B-NP	O
he	he	PRP	B-NP	O
again	again	RB	B-ADVP	O
developed	develop	VBD	B-VP	O
BRBPR	BRBPR	NN	B-NP	B-protein
.	.	.	O	O

Hct	Hct	NN	B-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
20	20	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
second	second	JJ	I-NP	O
RBC	RBC	NN	I-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	B-protein
received	receive	VBD	B-VP	I-protein
6	6	CD	B-NP	I-protein
more	more	JJR	I-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
PRBC	PRBC	NN	B-NP	B-cell_type
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MH	MH	NN	I-NP	B-DNA
MICU	MICU	NN	I-NP	I-DNA
on	on	IN	B-PP	O
10/21	10/21	CD	B-NP	O
.	.	.	O	O

Home	Home	NNP	B-NP	O
Meds	Med	NNPS	I-NP	O
:	:	:	O	O
allopurinol	allopurinol	NN	B-NP	O
300	300	CD	I-NP	O
QD	QD	NN	I-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
10	10	CD	I-NP	O
bid	bid	NN	B-VP	O
,	,	,	O	O
vioxx	vioxx	NN	B-NP	O
25	25	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
ranitidine	ranitidine	NN	B-NP	O
150	150	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
torsemide	torsemide	NN	B-NP	O
20	20	CD	I-NP	O
bi	bi	NN	I-NP	O
d	d	NN	I-NP	O
,	,	,	O	O
citalopram	citalopram	NN	B-NP	O
2o	2o	NN	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
ASA	ASA	NN	B-NP	O
325	325	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
celexa	celexa	NN	B-NP	O
20	20	CD	I-NP	O
qd	qd	NN	I-NP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
At	At	IN	B-PP	O
HDVH	HDVH	NN	B-NP	B-protein
initial	initial	JJ	I-NP	I-protein
hct	hct	NN	I-NP	I-protein
was	be	VBD	B-VP	I-protein
28.6	28.6	CD	B-NP	I-protein
.	.	.	O	O

The	The	DT	B-NP	O
pt	pt	NN	I-NP	O
remained	remain	VBD	B-VP	O
asympotomatic	asympotomatic	JJ	B-ADJP	O
,	,	,	O	O
though	though	IN	B-SBAR	O
he	he	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
bleed	bleed	VB	I-VP	O
and	and	CC	O	O
required	require	VBD	B-VP	O
repeated	repeat	VBN	B-NP	O
transfusions	transfusion	NNS	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7U	7U	NNP	I-NP	O
PRBC	PRBC	NNP	I-NP	B-cell_type
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noticed	notice	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
increased	increase	VBN	B-NP	O
PT	PT	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
1.4	1.4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
PLTs	PLT	NNS	B-NP	B-protein
to	to	TO	B-PP	O
108	108	CD	B-NP	O
and	and	CC	O	O
received	receive	VBD	B-VP	O
2units	2unit	NNS	B-NP	O
FFP	FFP	NN	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
unit	unit	NN	I-NP	O
PLTs	PLT	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
rectal	rectal	JJ	I-NP	O
bleeding	bleeding	NN	I-NP	O
after	after	IN	B-PP	O
8/10	8/10	CD	B-NP	O
.	.	.	O	O

Colonoscopy	Colonoscopy	NN	B-NP	O
on	on	IN	B-PP	O
8/10	8/10	CD	B-NP	O
showed	show	VBD	B-VP	O
diffuse	diffuse	JJ	B-NP	O
diverticulosis	diverticulosis	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
bleeding	bleeding	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
scope	scope	NN	I-NP	O
was	be	VBD	B-VP	O
unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
move	move	VB	I-VP	O
beyond	beyond	IN	B-PP	O
the	the	DT	B-NP	O
hepatic	hepatic	JJ	I-NP	O
flexure	flexure	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
lisinopril	lisinopril	NN	I-NP	O
and	and	CC	I-NP	O
torsemide	torsemide	NN	I-NP	O
were	be	VBD	B-VP	O
intially	intially	RB	I-VP	O
held	hold	VBN	I-VP	O
following	follow	VBG	B-PP	O
his	his	PRP$	B-NP	O
hypotensive	hypotensive	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
were	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
10/28	10/28	CD	B-NP	O
with	with	IN	B-PP	O
good	good	JJ	B-NP	O
effect	effect	NN	I-NP	O
.	.	.	O	O

An	An	DT	B-NP	O
initial	initial	JJ	I-NP	O
UA	UA	NNP	I-NP	O
showed	show	VBD	B-VP	O
75-80	75-80	CD	B-NP	O
WBC	WBC	NNP	I-NP	O
,	,	,	O	O
25-39	25-39	CD	B-NP	O
RBC	RBC	NNS	I-NP	O
and	and	CC	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
LE	LE	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
3	3	CD	B-NP	O
days	day	NNS	I-NP	O
levaquin	levaquin	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
c/o	c/o	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
>	>	SYM	I-NP	O
right	right	JJ	I-NP	B-protein
ankle	ankle	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
-	-	HYPH	B-VP	O
?	?	.	O	O

gout	gout	NN	B-NP	O
vs	vs	CC	I-NP	O
fx	fx	NN	I-NP	O
vs	vs	IN	B-PP	O
DVT	DVT	NN	B-NP	O
.	.	.	O	O

Relieved	Relieve	VBN	B-VP	O
with	with	IN	B-PP	O
tylenol/oxycodone	tylenol/oxycodone	NN	B-NP	O
.	.	.	O	O

Started	Started	JJ	B-NP	O
colchicine	colchicine	NN	I-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
GI/Heme	GI/Heme	NN	I-NP	O
:	:	:	O	O
Hct	Hct	NN	B-NP	O
30.7	30.7	CD	I-NP	O
no	no	DT	B-NP	O
BRBPR	BRBPR	NN	I-NP	B-protein
.	.	.	O	O

VSS	VSS	NN	B-NP	B-protein
,	,	,	O	O
checking	check	VBG	B-VP	O
hct	hct	NN	B-NP	O
BID	BID	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
source	source	NN	I-NP	O
of	of	IN	B-PP	O
bledding	bledde	VBG	B-VP	O
found	find	VBN	I-VP	O
.	.	.	O	O

Barium	Barium	NN	B-NP	O
enema	enema	NN	I-NP	O
to	to	TO	B-PP	O
ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
take	take	VB	I-VP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
indicated	indicate	VBN	B-VP	O
and	and	CC	O	O
avoid	avoid	VB	B-VP	O
vioxx	vioxx	NN	B-NP	O
,	,	,	I-NP	O
advil	advil	NN	I-NP	O
or	or	CC	I-NP	O
aspirin	aspirin	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
return	return	VB	I-VP	O
to	to	TO	I-VP	O
CH	CH	VB	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
colonoscopy	colonoscopy	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
your	your	PRP$	B-NP	O
right	right	JJ	I-NP	O
colon	colon	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
PCP	PCP	NN	I-NP	B-DNA
for	for	IN	B-PP	O
modification	modification	NN	B-NP	O
of	of	IN	B-PP	O
any	any	DT	B-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	O	O
concerns	concern	NNS	B-NP	O
about	about	IN	B-PP	O
you	you	PRP	B-NP	O
gout	gout	VBP	B-VP	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
return	return	NN	I-NP	O
t	t	VBP	B-VP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
should	should	MD	O	O
you	you	PRP	B-NP	O
again	again	RB	B-ADVP	O
develop	develop	VBP	B-VP	O
rectal	rectal	JJ	B-NP	O
bleeding	bleeding	NN	I-NP	O
,	,	,	O	O
che	che	NN	B-NP	O
or	or	CC	O	O
should	should	MD	O	O
you	you	PRP	B-NP	O
become	become	VB	B-VP	O
lightheaded	lightheade	VBN	I-VP	O
,	,	,	O	O
short	short	RB	B-ADVP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
also	also	RB	I-VP	O
work	work	VB	I-VP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
VNA	VNA	NN	I-NP	B-protein
for	for	IN	B-PP	O
improving	improve	VBG	B-VP	O
mobility	mobility	NN	B-NP	O
and	and	CC	O	O
follow	follow	VB	B-VP	O
the	the	DT	B-NP	O
nutrition	nutrition	NN	I-NP	B-cell_type
recs	rec	NNS	I-NP	I-cell_type
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
VNA	VNA	NN	B-NP	O
for	for	IN	B-PP	O
decub	decub	NN	B-NP	O
dressing	dress	VBG	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
home	home	NN	B-NP	O
PT	PT	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
GWALTHNEY	GWALTHNEY	NNP	B-NP	O
,	,	,	O	O
BUFORD	BUFORD	NNP	B-NP	O
JEFFEREY	JEFFEREY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
RF83	RF83	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2/5/02	2/5/02	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
41	41	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

